Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | November 15, 2006 | ||||
Last Updated Date | January 30, 2009 | ||||
Start Date † | September 2005 | ||||
Current Primary Outcome Measures † |
|
||||
Original Primary Outcome Measures † |
|
||||
Change History | Complete list of historical versions of study NCT00400127 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † |
|
||||
Original Secondary Outcome Measures † |
|
||||
Descriptive Information | |||||
Brief Title † | The Effect of Silicone Suspension on Standing Balance for Transfemoral Amputees | ||||
Official Title † | The Effect of Silicone Suspension on Standing Balance for Transfemoral Amputees | ||||
Brief Summary | The objective of this study is to test the hypothesis that silicone suction suspension without additional belt support does not significantly diminish the postural sway or walking performance of persons with transfemoral amputation. |
||||
Detailed Description | |||||
Study Phase | |||||
Study Type † | Interventional | ||||
Study Design † | Treatment, Randomized, Single Blind, Uncontrolled, Crossover Assignment, Safety/Efficacy Study | ||||
Condition † | Amputee | ||||
Intervention † | Device: Silesian suspension belt | ||||
Study Arms / Comparison Groups | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Terminated | ||||
Enrollment † | 25 | ||||
Completion Date | April 2007 | ||||
Primary Completion Date | April 2007 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 45 Years and older | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts †† | |||||
Location Countries † | Canada | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00400127 | ||||
Responsible Party | James Adderson, Capital District Health Authority, Canada | ||||
Secondary IDs †† | |||||
Study Sponsor † | Capital District Health Authority, Canada | ||||
Collaborators †† | |||||
Investigators † |
|
||||
Information Provided By | Capital District Health Authority, Canada | ||||
Verification Date | January 2009 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |